Pharmacy Practice Review

PPIs in GORD: supporting patients to step down

Discuss your patients' expectations of gastro-oesophageal reflux disease (GORD) management and assess their ongoing need for Proton-pump inhibitors (PPIs) with the aim of stepping down treatment.

  • Cost: free

F9Fa5A87Baa6A8F8 7834Cdbe9Bb9 Ppi Phpr 348X188Px




PPIs, as a class of medicines, are overprescribed, with data suggesting most of the PPIs prescribed in Australia are being used long term. Ongoing PPI use without a clear clinical indication could have more risks than benefit for the patient.

This Pharmacy Practice Review provides you with an opportunity to reflect on your support of patients who are using PPI medicines. Refresh your knowledge about long-term risks, adverse effects and other medicines that may make reflux symptoms worse. Review control of symptoms and identify patients who may benefit from stepping down their PPI treatment.

Choose from:

  1. Express version: 5 episodes of care (for up to 15 CPD credits) or
  2. Standard version: 10 episodes of care (for up to 24 CPD credits).

You will be given the option to submit your data once 5 episodes of care are entered, or continue to 10 episodes of care.



Pharmacy Practice Review quality assurance poster
Print and display the poster in your pharmacy

Frequently asked questions

Refer to the FAQs for more information.

See the Privacy and confidentiality details.